Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00808769 · ClinicalTrials.gov registry record · Phase 4
Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression
A Phase 4 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00808769: Completed Phase 4 study, sponsored by Procter and Gamble.
NCT00808769 is a Phase 4 study that has completed, run by Procter and Gamble. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00808769, a Phase 4 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
Primary Outcome
In this study, there was evidence of gastric pH probe failure and a high incidence of biologically improbable pH measurements (sustained pH \< 1.0) that bring the validity of the results into question. The results of this study are, therefore, inconclusive.
Interventions
- DRUG Zegerid®
- DRUG Prilosec OTC®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
What the finished NCT00808769 record still lists
NCT00808769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Zegerid® is the first listed.
NCT00808769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00808769 about?
NCT00808769 is a clinical study titled "Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression". The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
What is the current status of trial NCT00808769?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-11. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00808769?
The interventions under investigation include: Zegerid® (DRUG), Prilosec OTC® (DRUG).
Who is sponsoring clinical trial NCT00808769?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00808769's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia